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PREFACE  
The present Ph.D. thesis is partly based on the below three research papers. The 
experiments have been accomplished at the Integrative Neuroscience Group, SMI, 
Department of Health Science and Technology, Faculty of Medicine, Aalborg 
University, Denmark, in the period from 2012 to 2016. The results in details of the 
three experimental studies are documented in the three papers.  
1. Xia, W.
1
, Mørch, C.D.
1
, & Andersen, O.K
1
. (2016) Exploration of the 
conditioning electrical stimulation frequencies for induction of long-term 
potentiation-like pain amplification in humans. Exp. Brain Res. (Epub ahead of print) 
1. Center for Neuroplasticity and Pain (CNAP), SMI, Department of Health Science 
and Technology, Aalborg University, Aalborg, Denmark.  
DOI:10.1007/s00221-016-4653-1 
 
2. Xia, W.
 1
, Mørch, C.D.
 1
, & Andersen, O.K
1
. (2016) Test-retest reliability of 10 
Hz conditioning electrical stimulation inducing long-term potentiation-like pain 
amplification in humans. (accepted for publication in PLOS ONE) 
1. Center for Neuroplasticity and Pain (CNAP), SMI, Department of Health Science 
and Technology, Aalborg University, Aalborg, Denmark. 
DOI:10.1371/journal.pone.0161117 
 
3. Xia, W.
 1
, Mørch, C.D.
 1
, Matre, D.
2
, & Andersen, O.K
1
. (2016) Exploration of 
conditioned pain modulation on long-term potentiation-like pain amplification in 
humans. (submitted to European Journal of Pain) 
1. Center for Neuroplasticity and Pain (CNAP), SMI, Department of Health Science 
and Technology, Aalborg University, Aalborg, Denmark. 
2. National Institute of Occupational Health, Department of Work Psychology and 
Physiology, Oslo, Norway. 
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ENGLISH SUMMARY 
Chronic pain is a worldwide health problem. It not only lowers the life quality of 
the patients, but also takes a lot of social economic cost. However, chronic pain 
treatments now are still not ideal and developing an efficient analgesic therapy is 
persistent challenge. Therefore, exploring the mechanisms behind pain 
chronification and endogenous pain modulation is still the medical priority. Long-
term potentiation (LTP) is an important feature of synaptic plasticity in the central 
nervous system. Spinal nociceptive LTP induced by high frequency conditioning 
electrical stimulation (CES) has been considered to be a potential mechanism 
underlying central sensitization demonstrated as hyperalgesia and allodynia in 
clinical patients. However, it is still questionable on the biological significance of 
high frequency CES paradigm as actually the low frequency discharging of 
nociceptors plays the critical role inducing central sensitization. Conditioned pain 
modulation (CPM) is a kind of endogenous pain inhibitory modulation. A better 
understanding of the balance between CPM inhibition and pain facilitation is 
crucial to understand the importance of endogenous pain inhibition in the 
prevention of LTP-like pain amplification in humans. 
The aims of the present Ph.D. project were to: investigate the different CES 
paradigms to induce pain LTP in healthy humans in order to find a paradigm more 
like inflammatory/neuropathic pain conditions (study I); show the reliability of the 
corresponding measurements indicating LTP-like pain amplification and 
inflammation responses, and calculate sample sizes for potential drug testing 
studies (study II); assess the pain inhibitory effect of CPM on the development of 
pain LTP (study III).  
In study I, 10 Hz CES induced heterotopic pain amplification like the high 
frequency (100, 200 Hz) CES but associated a less pain experience during the CES 
process, however, homotopic pain amplification were absent in all paradigms. In 
study II, the test-retest reliability results for 10 Hz CES paradigm showed that 
superficial blood flow is reliable indicator for neurogenic inflammation response; 
painful pinprick and light stroking stimuli are reliable indicators for measuring 
heterotopic perception amplification. In study III, CPM induced by cold pressor 
conditioning stimulus inhibited the development of heterotopic perception 
amplification to non painful mechanical stimuli but no effect was observed to  
heterotopic pinprick painful stimulus, homotopic electrical stimuli and peripheral 
inflammation responses.  
 
In conclusion, the present work has provided more information on pain LTP 
induction in healthy human models and recommends 10 Hz CES paradigm in 
potential analgesic studies because of the biological significance. The endogenous 
VI 
pain inhibition effect of CPM may play a role in modulating pain amplificatory 
system. 
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DANISH SUMMARY 
Kronisk smerte er et verdensomspændende sundhedsproblem. Det handler ikke kun 
om lavere livskvalitet for patienterne, men også om en række social-økonomiske 
omkostninger. Behandlingen af kroniske smerter er i dag ikke optimal og 
udviklingen af effektive smertestillende terapier er en vedvarende udfordring. 
Udforskning af de underliggende mekanismer bag hvorfor smerte kan ende med at 
blive kroniske og en bedre forståelse af endogen smerte modulation har derfor stor 
prioritet. Long Term Potentiation (LTP) er en vigtig mekanisme i den synaptiske 
plasticitet i centralnervesystemet. Spinal LTP i det nociceptive system induceret er 
anset for at være en potentiel underliggende mekanisme bag central sensibilisering 
som manifesterer sig som hyperalgesi og allodyni hos patienter. LTP i 
smertesystemet kan induceres af højfrekvent konditionerende elektrisk stimulation 
(CES). Anvendelse af højfrekvent CES paradigmet til inducering af central 
sensibilisering er dog fysiologisk problematisk, idet nociceptorer i reglen fyrer ved 
lave frekvenser (få aktionspotentialer per sekund). Conditioned Pain Modulation 
(CPM) igangsætter endogen smerte hæmmende modulation. En bedre forståelse af  
balancen mellem CPM inhibering og smerte sensibilisering er afgørende for at 
forstå betydningen af endogen smerte inhibering i forebyggelse af LTP-lignende 
smerte sensibilisering hos mennesker. 
Formålet med nærværende ph.d. projekt var 1) at undersøge forskellige CES 
paradigmer til at inducere smerte LTP i raske forsøgspersoner for at finde et 
brugbart paradigme, der i højere grad minder om inflammatoriske/neuropatiske 
smertetilstande (studie I); 2) vise pålideligheden af de valgte effektmål for LTP-
lignende smerte sensibilisering og for måling af vaskulære reaktioner efterfulgt af 
teoretiske beregninger af stikprøvestørrelser for fremtidige potentielle kliniske 
afprøvninger (studie II); 3) vurdere den smerte-inhibitoriske virkning af CPM på 
udviklingen af smerte LTP (studie III). 
I studie I inducerede 10 Hz CES heterotopisk smerte sensibilisering lige så effektivt 
som højfrekvent (100, 200 Hz) CES, dog forbundet med en mindre smerte 
oplevelse under CES processen. Homotopisk smerte sensibilisering var fraværende 
i alle tre paradigmer. I studie II viste test-retest pålideligheden for 10 Hz CES 
paradigmet, at den superficielle blodgennemstrømning er en pålidelig indikator for 
neurogen inflammation og at smertefulde nåleprik og let berøring er pålidelige 
indikatorer for heterotopisk smerte sensibilisering. I studie III hæmmede CPM 
udløst ved cold-pressor smerte udviklingen af heterotopisk smerte sensibilisering til 
ikke-smertefulde mekaniske påvirkninger (allodyni). Der var dog ingen virkning på 
heterotopisk nåleprik, homotopiske elektriske stimulationer eller på målinger af 
perifere vaskulære reaktioner . 
VIII 
Dette ph.d. arbejde har givet ny viden om induktionen af LTP i smertesystemet i 
raske forsøgspersoner. Samlet set anbefales et 10 Hz CES paradigme i fremtidige 
eksperimentelle studier grundet den tættere knytning til normal patofysiologi. 
Endeligt kan det konkluderes, at den endogene smerte hæmmende effekt af CPM 
kan spille en rolle i smerte sensibiliseringsmekanismer.
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1. INTRODUCTION 
1.1. BACKGROUND 
 Central Sensitization and Pain-LTP 
According to the definition made by International Association for the Study of Pain 
(IASP), pain is “an unpleasant sensory and emotional experience associated with 
actual or potential tissue damage, or described in terms of such damage”. Pain is 
ubiquitous in our daily life, but the underlying mechanism is quite complicated and 
unclear. There are a huge number of people suffering from a variety of pain 
conditions lowering their quality of life, both in mental and physical aspects. Pain 
has a protective function for the body and is necessary to promote healing after 
injury. However, if pain persists with the absence of ongoing nociceptive input or 
pain exceed the normal response to ongoing nociceptive stimuli, pain is considered 
to be maladaptive; especially in chronic pain states, such as neuropathic and 
inflammatory dysfunctional pain, as pain no longer has a protective function. 
(Costigan et al., 2009).  
Chronic pain has become a serious worldwide public health problem, and this takes 
a lot of social and family economic costs (McCarberg & Billington, 2006). 
However, the outcomes of the treatments for chronic pain are still unsatisfactory 
and effective pain medications are persistent challenging (Ossipov & Porreca, 2005; 
Backonja et al., 2006; Finnerup et al., 2010). Therefore, improving chronic pain 
treatments is obviously a significant medical priority. A better understanding of the 
mechanisms underlying pain chronification and pain amplification, as well as those 
underlying the endogenous pain modulation systems, will help to further know the 
human pain system. Hopefully, this may help to develop novel medical treatments 
against chronic pain states. 
As seen in inflammation or nerve injury conditions, persistent low frequency 
discharging of peripheral nociceptors (below 10 Hz; mainly C-fiber type) could 
lead to an enhanced response of spinal dorsal horn neurons to incoming afferent 
stimuli, a condition that is termed “central sensitization”, i.e., enhanced pain 
perception to noxious stimuli (hyperalgesia) and pain perception induced by 
normally non-noxious stimuli (allodynia) (Woolf, 1983; Basbaum & Julius, 2006; 
Woolf & Ma, 2007; Costigan et al., 2009). Many chronic pain patients show 
features of central sensitization (Banic et al., 2004; Nijs et al., 2010). Central 
sensitization is characterized by facilitation of pain transmission pathways which 
involves increases in the spontaneous activity of nociceptors, evoked responses and 
enlarged receptive field, and lowered response thresholds of wide dynamic range 
(WDR) and nociceptive specific (NS) dorsal horn neurons (Suzuki et al., 2002, 
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2004; Suzuki & Dickenson, 2005; Basbaum & Julius, 2006; Woolf & Ma, 2007; 
Costigan et al., 2009).  
Long-term potentiation (LTP) is an important feature of synaptic plasticity in the 
central nervous system and was considered to be involved in learning and memory 
formation in the hippocampus (Bliss & Lomo, 1973; Blanchard et al., 2010). LTP 
was presented as a long-lasting enhancement of synaptic transmission efficiency in 
the central nervous system (Bliss & Collingridge, 1993).  Moreover, it has been 
shown that a form of LTP is also involved in the nociceptive pathways in the spinal 
synapses, and an enhanced responsiveness of spinal dorsal horn neurons were 
present in both slice preparations in vitro and animal experiments in vivo (Randić et 
al., 1993; Sandkühler, 2000; Ikeda et al., 2003). An important underlying 
mechanism has been considered to be involving LTP of the C-fibre synapses 
mediating nociceptive transmission located at the superficial and deep spinal dorsal 
horn (Randić et al., 1993; Ikeda et al., 2003). Therefore, LTP of nociceptive 
synaptic transmission has been considered to be one important mechanism 
underlying central sensitization, i.e., its perceptual correlate of neurogenic pain 
amplification (hyperalgesia and allodynia) (Ji et al., 2003; Klein et al., 2004). 
 Pain-LTP Induction Methodologies  
Many experimental models of pain facilitation have been used for exploring the 
underlying mechanisms or evaluating analgesic agents in healthy humans, including 
1) electrical nerve stimulation: high frequency stimulation (HFS) at 100 Hz (1~2 ms 
pulse duration) for 1 s, repeated 5 times with 10 s intervals (Klein et al., 2004, 2008; 
Hansen et al., 2007; van den Broeke & Mouraux, 2014a; Study I) or continuous 
intermediate frequency electrical stimulation at 5 or 10 Hz (0.5~1 ms pulse duration) 
(Chizh et al., 2004; Koppert et al., 2004; Bandschapp et al., 2010; Study I, II, III); 2) 
natural noxious stimulation: skin incision (Kawamata et al., 2002), chemical injury, 
such as capsaicin, mustard oil or formalin (LaMotte et al., 1991; Treede et al., 1992; 
Pertovaara, 1998), and thermal injury, such as heat or UVB burn (Modir & Wallace, 
2010a, 2010b); 3) pharmacological stimulation: opioid withdrawal during 
intermediate frequency electrical stimulation or after capsaicin injection (Angst et 
al., 2003; Hood et al., 2003) or acute opioid withdrawal (Compton et al., 2003). In 
addition to the induced homotopic hyperalgesia at the site of injury (primary 
hyperalgesia), these models also produce heterotopic mechanical hyperalgesia to 
pinprick stimulation (secondary hyperalgesia) and allodynia to light touch 
stimulation in the surrounding area without injury.  
LTP can be induced by high frequency conditioning electrical stimulation (CES) in 
the brain (Bliss & Lomo, 1973). Similarly, conditioning electrical stimulation of 
peptidergic nociceptive C-fibre afferents can lead to LTP of synaptic transmission 
in the spinal cord at high frequency (100 Hz), low frequency (1~2 Hz), or 
intermediate frequency (10 Hz) in vivo and in vitro (Randić et al., 1993; Yang et al., 
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2014; Kim et al., 2015). In healthy humans, the most typical paradigm inducing 
pain LTP is conditioning HFS using the special epicutaneous pin electrodes (EPE) 
which can selectively activate C-fibre nociceptors compared to conventional patch 
electrode (Klein et al., 2004, 2008; Hansen et al., 2007; van den Broeke & 
Mouraux, 2014a; Study I, II, III). In contrast, CES at low frequency (1 Hz, 1000 
pulses) induced perceptual LTD (long-term depression) rather than LTP in humans 
(Klein et al., 2004; Rottmann et al., 2010). Therefore, compared with animal and 
slice preparation studies, there are some opposite findings in human studies. In most 
neuropathic or inflammatory pain conditions, however, hyperalgesia is caused by 
persistent low frequency discharging of C-fibre nociceptors (i.e., 0.3~10 Hz) which 
is far different from the electrical HFS paradigm used in experiments to produce 
LTP-like pain amplification (Puig & Sorkin, 1996; Han et al., 2000; Xiao & 
Bennett, 2007a; Drdla & Sandkuhler, 2008). HFS may mimic the high frequency 
discharge of nociceptors at the beginning of injury (Handwerker et al., 1987). 
Therefore, it is still difficult for CES to fully resemble the irregular discharging of 
nociceptors and still be reproducible in humans. However, frequencies closer to the 
firing frequencies of nociceptors under pain conditions still need to be explored for 
inducing a similar LTP-like pain amplification in humans. 
 Pain-LTP Measurements 
Psychological measurements of central neuronal sensitization are focusing on 
observing the reduction of pain threshold/increased pain response at the injured 
sites and spread of pain to uninjured sites. The assessments of cutaneous CES-
induced LTP-like pain amplification include pain perception ratings at the 
conditioned sites stimulated by EPE (homotopic) and in the immediate vicinity to 
the EPE (heterotopic). The homotopic pain amplification was assessed using single 
electrical stimulation at the conditioned sites and this is thought to share 
characteristics of homosynaptic LTP (Klein et al., 2004; van den Broeke & 
Mouraux, 2014b). The heterotopic pain amplification was assessed by mechanical 
stimuli, such as punctate probes, soft brush or cotton swab which is thought to share 
characteristics of heterosynaptic LTP (Klein et al., 2004; van den Broeke et al., 
2011). The thermal modalities, e.g., heat pain threshold, are important 
measuremenst of hyperalgesia involved in animal and human models (Hargreaves 
et al., 1988; Lang et al., 2007; Sumikura et al., 2003). The TRPV1 receptors in 
spinal dorsal horn have been shown to contribute to spinal LTP induction and 
development (Yang et al., 2014). Activation of afferent fibers by heat may involve 
the TRPV1 ion channel which helps to produce heat pain perception (Caterina et al., 
1997). Heat stimulation has been used to assess peripheral sensitization in CES 
model. However, there were still controversies about the presence of heat pain 
hyperalgesia in previous studies on CES human model (Lang et al., 2007; van den 
Broeke & Mouraux, 2014b).  
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After being activated by nociceptive CES, axon reflex occurs on peptidergic C-fiber 
nerve endings which can release neuropeptides, such as substance P (SP), calcitonin 
gene-related peptide (CGRP) (Sauerstein et al., 2000), resulting in neurogenic 
vasodilatation, plasma and protein extravasation, attraction of macrophages, or 
degranulation of mast cells, which was termed “neurogenic inflammation” (Jancsó 
et al., 1967; Lynn, 1996; Schaible et al., 2005; Schaible, 2007). The neurogenic 
inflammation can be assessed by measuring the superficial blood flow (SBF) and 
temperature of the skin which can be representatives of the peripheral processes 
(Magerl & Szolcsányi, 1987; Klein et al., 2004; Study I, II, III).  
 Conditioned Pain Modulation (CPM)  
A conditioning painful stimulus can inhibit the nociceptive response evoked by a 
test stimulus located at a remote extra-segmental body area which was named 
“diffuse noxious inhibitory control (DNIC)” (Le Bars et al., 1979b). Afterwards, 
the term “conditioned pain modulation (CPM)” has been introduced involving a 
broader description of “pain inhibits pain” phenomenon in humans. CPM effect 
refers to that perceived pain intensity caused by a test stimulus can be inhibited by a 
conditioning painful stimuli applied at a remote location of the body (Yarnitsky et 
al., 2010). CPM is considered to be an important manifestation of endogenous 
descending inhibitory modulation (Yarnitsky et al., 2010). The CPM effect has 
been shown to inhibit the activity of spinal neurons involved in nociceptive 
pathways resulting in decreased hyperalgesia and nociceptive responsiveness in 
animals (Bouhassira et al., 1992) and pain perception in humans (Meeus et al., 
2008; Villanueva, 2009; Roussel et al., 2013). The mechanisms underlying CPM is 
thought to involve multiple pain modulatory pathways, such as the activation of 
cortical (anterior cingulate cortex, orbitofrontal cortex and amygdala) and brainstem 
(periaqueductal gray and medulla) structures mediating nociception via descending 
inhibitory serotonergic and noradrenergic systems leading to inhibition of wide 
dynamic range (WDR) neurons located  in deep spinal dorsal horn (Le Bars et al., 
1979b; Bouhassira et al., 1992; Le Bars, 2002; Piché et al., 2009; Nir et al., 2011; 
Sprenger et al., 2011). Furthermore, CPM efficiency has been suggested as a 
biomarker of central endogenous descending inhibition integrity in patients with 
chronic pain. The CPM effect has been shown to be less efficient in these patients 
(van Wijk & Veldhuijzen, 2010; Chalaye et al., 2014; Corrêa et al., 2015), 
suggesting that the central endogenous inhibitory system is dysfunctional 
(Yarnitsky, 2015). Interestingly, populations with deficient CPM effect could be at 
risk for having the chronic postoperative pain (Yarnitsky et al., 2008; Wilder-Smith 
et al., 2010). Chronic pain can be the consequence of the imbalance of pain 
inhibition and pain facilitation systems. In human studies, the cold pressor 
conditioning stimulus (CPCS) is most used to induce CPM effect because of its 
better reliability compared with pressure pain or tourniquet pain methods (Oono et 
al., 2011; Lewis et al., 2012). Until now, the endogenous pain modulation 
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mechanisms on pain facilitation are still not clear, and an effective chronic pain 
treatment strategy is a persistent challenge. 
1.2 AIMS AND HYPOTHESIS  
Based on the background information above, three studies were designed and 
performed (Fig. 1) and the hypothesis and aims of this Ph.D. project are presented 
as below: 
In study I:  We hypothesized that 10 Hz CES closer to the discharging frequency of 
C-fibres during natural pain conditions might be superior for induction of LTP-like 
pain amplification. This experimental protocol in humans aimed to explore the 
conditioning electrical stimulation frequencies standing on a biological significance 
to induce cutaneous long-term potentiation (LTP)-like pain amplification in humans.  
 
In study II: According to the results of study I that 10 Hz CES could be used as an 
alternative paradigm for inducing heterotopic LTP-like pain amplification in 
humans, but no studies have been done to do the test-retest reliability of 10 Hz 
CES-induced inflammatory and sensory outcomes. The primary aim of this study 
was to quantify and evaluate the test-retest reliability of long-term potentiation 
(LTP)-like pain amplification and inflammatory responses induced by 10 Hz CES 
with cross-over and parallel study designs in humans. By calculating hypothetical 
sample sizes, it will be helpful for researchers when using this model for future 
pharmacological testing studies.   
 
Study III: We hypothesised that CPM might have an inhibitory effect to decrease 
the sensitization of central nervous system which might prevent the induction of 
LTP-like pain amplification by 10 Hz CES in healthy humans. The aim of this 
study was to assess the endogenous perceptual inhibitory modulation on LTP-like 
pain amplification in humans. 
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Aims 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Study  
 
Fig. 1 Ph.D. project aims and design.  
The 100 Hz CES (500 pulses, pulse width at 1 ms) was given as five 1-s trains with 10 s 
intervals. The 200 Hz CES was given as five 0.5-s trains with 10 s intervals (500 pulses, 
pulse width at 1 ms). The 10 Hz CES was given as continuous train for 50 s (500 pulses, 
pulse width at 1 ms). Arrow: Study I; bold arrow: Study II; swallowtail arrow: Study III. 
CPCS: cold pressor conditioning stimulus. 
CPCS/ 
Control  
Explore the CES 
frequencies inducing 
pain LTP in humans (I) 
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2. OVERVIEW OF THE PH.D. WORK 
2.1. EXPERIMENTAL STUDIES  
Based on the hypothesis, three experimental studies were designed in this Ph.D. 
project (Fig. 1): 
In study I, three CES paradigms (10 Hz, 100 Hz and 200 Hz) were applied to 
induce pain LTP in three sessions and observe the corresponding neurogenic 
inflammation responses in fifteen healthy subjects (7 females). The three paradigms 
include 1) 10 Hz lasting 50 sec, 2) 100 Hz lasting 1 sec repeated five times with 10 
sec intervals, 3) 200 Hz lasting 0.5 sec repeated five times with 10 sec intervals. All 
CES process in each CES paradigm lasted 50 sec and consisted 500 rectangular 
pulses (pulse width: 1 ms) with stimulation intensity at 10  detection threshold 
(DTh). The three CES paradigms and the control session without applying any CES 
were randomly arranged on four separate days with at least one-week interval (Fig. 
2B).  In study II, only the 10 Hz paradigm which was the same 10 Hz paradigm 
used in study I was applied to induce pain LTP and the corresponding neurogenic 
inflammation responses were observed in twenty healthy subjects (8 females). This 
paradigm was repeated applied for each subject on two separate days with at least 
one week interval (Fig. 2C). In study III, the LTP-like pain amplification was 
induced using the 10 Hz paradigm by the EPE. Conditioned pain modulation effect 
was induced by the cold pressor test (CPT) applied as the conditioning stimulus at a 
remote body location (left foot) from the CES stimulated area (right forearm). Two 
experimental sessions (CPCS/control) were randomly scheduled for twenty subjects 
(6 females) on two separate days with at least one-week interval in a cross-over 
design. Half of the subjects experienced CPCS session as the first experimental 
session, and the other half of the subjects experienced control session as the first 
experimental session. This was aimed to reduce the bias because of the sequence of 
the two sessions. A training session was arranged for each subject before 
experimental sessions in three studies to be familiar with the different stimulus 
modalities and to know how to rate perception intensities to these test stimuli using 
the visual analogue scale (VAS). All the perception intensity measurements were 
done by the same tester.  
2.2. EXPERIMENTAL METHODOLOGY  
2.2.1. LONG-TERM POTENTIATION (LTP)-LIKE PAIN MODEL 
The epicutaneous pin electrode (EPE) was used in this project to induce pain LTP 
by conditioning electrical stimulation (CES). The EPE has a circular of fifteen 
cathodal pin electrodes (diameter: 10 mm; area: 79 mm
2
) with diameter of 0.2 mm 
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protruding from the base; the anode is a large circular stainless steel with an inner 
diameter of 20 mm and an outer diameter of 40 mm placed concentrically around 
the pin cathodes (Fig. 2A) (Biurrun Manresa et al., 2010). Compared with the 
conventional patch electrode, the EPE could induce pain/stinging sensation with 
lower electrical stimulation intensity because the diameter of the cathodes is smaller 
leading to a high current density in the epidermal layers where the nociceptive Aδ- 
and C-fibers terminate (Nilsson et al., 1997; Mouraux et al., 2010; Mørch et al., 
2011). The EPE was placed on the right forearm 7 cm distal to cubital fossa (i.e., 
conditioned sites). The EPE was connected to the constant current stimulator (DS5; 
Digitimer Ltd; Welwyn Garden City, UK) which generates the 1 ms square pulses 
electrical stimulation. The method of limits was used to determine the individual 
electrical detection threshold (DTh): three series of electrical pulses with increasing 
and decreasing stimulus intensities at a step size of the 3% present stimulation 
intensity. In each series of stimulation pulses, all subjects terminated the electrical 
stimulation with increasing intensities when detecting the electrical pulse, and then 
terminated the electrical stimulation with decreasing the intensities when the 
electrical pulse became insensible. This process was repeated three times. The DTh 
was recorded using the electrical stimulus intensity they terminated the electrical 
stimulation each time. The geometric mean of the six DThs measured in three series 
of assessments was used as the final DTh. 
2.2.2. PAIN PERCEPTION MEASUREMENTS  
The visual analogue scale (VAS) was used to evaluate perceived stimulation 
intensities. In study I, the VAS was anchored from 0 (no pain) to 10 (the most 
intense pain imaginable) with a custom made slide ruler. In study II and III, the 
VAS was anchored from 0 (no sensation) to 100 (the most intense pain imaginable) 
where 30 indicated the pain threshold. According to the experience in study I, the 
VAS used in study II and III is likely a more reasonable way, as sometimes the 
subjects may still slide a small number even the stimulation is just close to 
becoming painful. 30 indicated the pain threshold means all subjects should rate 
non-painful stimulation under 30 and rate painful stimulation above 30 on this scale. 
This is a way of merging two rating scales (with pain threshold in the middle) for 
painful and non-painful stimulation which actually activate different sensory nerve 
endings. Two rating scales used in one study may confuse the subjects when rating 
the perception intensities to different intensities of stimuli. There are some other 
studies involving healthy humans and clinical patients which also used a similar 
pain rating scale (Matre et al., 2006; Biurrun Manresa et al., 2010; Dawson et al., 
2012; Mørch et al., 2013). The reason we changed the 10-scale is that 100-scale 
may help to do possible log10 conversion of raw data in the statistic analysis.  
In study I, II, and III, the perception intensity during the CES process (i.e., 50 s) in 
each paradigm in each session was rated by the subjects using a hand-held VAS-
device. The recorded pain ratings were sampled in a computer. Then the highest 
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pain rating in each 10 s stimulation was chosen to observe and compare the 
temporal changes within and between sessions. The short-form McGill Pain 
Questionnaire (SF-MPQ) was used to further describe the pain intensity and quality 
of the CES process in each experimental session. The SF-MPQ consists of sensory 
and affective dimensions of pain, evaluative overall intensity of total pain 
experience and present pain intensity index of the standard MPQ. The present pain 
intensity is the average pain rating subjects gave to the whole conditioning process 
after conditioning stimulation. All rating scores were added together to get a total 
quantitative value for comparison between different CES paradigms (Melzack, 
1987). 
The heterotopic non-painful tactile mechanical perception was assessed by a cotton 
swab stroking surrounding the conditioned sites. The cotton swab has a flexible 
plastic mount which can exert ~100 mN when slightly bent. The perception was 
measured by a light-stroking stimulus with a distance of 1 cm moving at a speed of 
1-2 cm/s each time. In study I, the area of allodynia was measured by light stroking 
stimulus moving from outside to the centre of the circular pin electrodes in four 
directions (Fig. 2A). The area was calculated by connecting the four recorded 
positions where the stroking perception became painful/unpleasant. In study II, 
instead of measuring area of allodynia, we measured the perception intensity to the 
light stroking stimulus which stopped at 1 cm to the border of circular pin 
electrodes. The stoking speed was the same with study I. An average of the four 
tests by a VAS scale in four sites was used as the final perception intensities for 
light-stroking stimuli. The method used to measure perception intensities to light 
stroking stimuli in study III was the same with the method used study II (Fig. 2A ). 
The heterotopic mechanical pinprick perception was measured by a set of custom-
made weighted pinprick stimulators (SMI®, Aalborg University, round tip, 0.2 mm 
in diameter, contact time 1~2 s) applied surrounding the conditioned sites (i.e. 
15~20 mm to the circular pin electrodes) (Fig. 2A ). In study I, two weighted 
pinprick stimulators (12.8 g and 30 g) were used. In study II, three weighted 
pinprick stimulators (12.8 g, 30 g and 50.1 g) were used.  We employed a heavier 
weight pinprick stimulator (i.e., 50.1 g) in study II because we aim to perform the 
test-retest reliability, therefore a more broad range of weighted stimulators is 
needed to compare and confirm the more reliable pinprick stimulator for measuring 
the mechanical pinprick LTP-like perception amplification. In study III, The 
heterotopic mechanical perception was measured by three custom made weighted 
pinprick stimulators (12.8 g, 30 g, 50.1 g) which were the same with the stimulators 
used in study II.  
The homotopic perception to single electrical stimulation (SES) was assessed at the 
conditioned sites using the same EPE (Fig. 2A). SES used single electrical square 
pulse stimulus (pulse duration: 1 ms) with stimulation intensity at 10 DTh. An 
average value of three SES tests with 10 s intervals was used as the final perception 
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intensity to SES. The methods for measuring homotopic perception to SES were the 
same in Study I, II, and III.  
The heat pain threshold (HPT) was measured for observing thermal perception 
changes by a heat stimulator with a contact thermode (Pathway; 30×30 mm ATS; 
Medoc Ltd.; Ramat Yishai, Israel) placed on the forearm concentric to the circular 
pin electrodes. The stimulated area covered both conditioned and surrounding skin 
areas as the area of the contact thermode is bigger than the area of circular pin 
electrodes. The baseline temperature was 32℃. The temperature increased at a 
speed of 1℃/s and returned to the baseline at a speed of 8℃/s. All subjects pressed 
a response button to terminate the ramping heat stimulation when the heat pain was 
detected. An average value of three tests was used as the final HPT. The methods 
for measuring HPT were the same in study I, II, and III.  
2.2.3. INFLAMMATION MEASUREMENTS  
The inflammation response at the skin after CES was assessed by observing the 
superficial blood flow (SBF) and skin temperature (ST) with imaging recordings in 
study I, II, and III. Full-Field Laser Perfusion Imager (FLPI) (MoorFLPI; Moor 
Instruments Ltd, Axminister, Uk) was used to observe the possible excitation of 
peptidergic nerve fibres (mainly C-fibres) and assess the temporal changes of SPF 
(i.e., neurogenic inflammation) in the area surrounding the conditioned sites. The 
infrared thermography (Thermovision A40; FLIR; Danderyd, Sweden) was used to 
measure the ST surrounding the conditioned site. The SBF and ST were assessed in 
the same round area with a diameter of 15 mm concentric to the circular pin 
electrodes which however did not cover the area of pinprick stimuli. 
2.2.4. CONDITIONED PAIN MODULATION (CPM)  
In study III, subjects immersed the left foot in the circulated cold ice water (i.e., 
cold pressor test) at the ankle level for CPM induction. There was a steel mesh in 
the bucket to prevent the direct contact between ice and foot. The temperature of the 
cold water bath was 4℃±1℃. All subjects could withdraw the foot from the water 
bucket if the cold water pain became intolerable. However, they were encouraged to 
place back the foot as soon as they could. A warm, comfortable water bath (32℃) 
was used in the control session. The CPCS/ control water bath lasting two minutes 
was applied immediately before 10 Hz CES in each session (Fig. 2D).  
2.2.5. DATA ANALYSIS  
In study I, two-way repeated measures (RM)-ANOVA was done on the pre-
conditioning data to determine any significant differences before CES between four 
sessions (control, 10 Hz, 100 Hz and 200 Hz) in any of the outcome measures. To 
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strengthen the statistical analysis, only post-CES measurements were included in 
the RM-ANOVA to identify hyperalgesia in comparison with the control condition 
and to compare the three conditioning frequencies. RM-ANOVA was done on the 
whole data (pre- and post-conditioning period) in study II and III. In study III, the 
normalized data of pain perception measurements were used for analysis whereas 
study I and II used raw data, as 1) pain intensity increments (percentage of baseline 
data) can be used for presenting pain perception changes intuitively and better 
present the sensation changes on different days to the same stimulation equipment 
for each subject; 2) according to study II, subjects may have different sensitivities 
on different days due to different conditions of the body (i.e., giving different 
responses to the same stimulation), so normalization will strengthen analysis as the 
difference in the baseline data might lead to a wrong proposed difference between 
two sessions. In all three studies, Greenhouse-Geisser method was used for 
correction of non-sphericity. Bonferroni-Holm adjustment was used for multiple 
comparisons. In study II, the reliability was assessed using intra-class correlation 
coefficient (ICC), coefficient of variation (CV) and Bland-Altman analysis. Sample 
sizes were calculated for potential crossover and parallel study designs. The 
calculation formulas were: Nparallel=(15.6×σ
2
)/E
2
; Ncrossover=(15.6×σ
2
×(1-
ICC))/E
2
. The clinical relevant effect (E) was set at 30% of the difference between 
the average baseline value and the average value of three time points (10, 20, 30 
min) after CES. σ is the average value of the standard deviation of post-CES values 
at three time points. ICC was calculated in within sessions. This was also 
considered to be a valid alternative approach for assessing reliability (Mørch et al., 
2013; Biurrun Manresa et al., 2014). 
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Fig. 2 Experiment setup for Study I, II, and III . A. The EPE was placed on the right forearm 
7 cm to the cubital fossa. The homotopic pain ratings to SES were tested at the conditioned 
sites after CES using the same EPE. The heterotopic perception intensity to pinprick and 
light-stroking stimuli were tested in the area surrounding the circular pin electrodes. B. 
Study I procedure. C. Study II procedure. D. Study III procedure. B,C,D. A series of 
assessments including pain ratings to SES, pinprick and light-stroking stimuli, HPT, 
neurogenic inflammation (SBF,ST) was repeated three times before and six times after CES 
with 10 min intervals in each session. D. Study III procedure. CPCS and control water bath 
lasting for 2 min on the left foot was applied immediately before 10 Hz CES in each session. 
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2.3. PERCEPTION FEATURES OF CES 
 Main results  
In study I, we found that the perception intensities during the 100 Hz CES process 
increased whereas no temporal changes were found for 10 Hz and 200 Hz CES 
process. 100 Hz CES caused a higher pain rating  than 200 Hz CES in the first 10 s 
stimulation. The SF-MPQ score for 10 Hz CES process was lower than 100 Hz 
CES process indicating less pain during the 10 Hz process. In study II, the pain 
ratings declined during the CES process in both sessions and session one induced 
higher pain ratings than session two. In study III, the pain perception ratings 
declined during the train of 50 s 10 Hz CES process. Pain perception ratings in the 
CPCS session were found to be lower than perception ratings in the control session.  
 Discussion  
In study I, the pain perception intensity increased during the 100 Hz CES process 
which is in agreement with Klein’s study (Klein et al., 2004). The 100 Hz CES 
caused higher pain intensities than 200 Hz for the first 10 sec stimulation which 
may be due to conduction failure of the impulses. The interstimulus interval for 
transferring the same amount of impulses was shorter in 200 Hz CES (5 ms) 
compared to 100 Hz CES (10 ms). It has been reported that C-fibres could reach the 
maximum discharge frequency of 190 Hz with the entrainment interval (i.e., 
absolute refractory period+relative refractory period) of 5.3 ms indicating that 200 
Hz CES is likely to be associated with less efficiency of afferent input to the spinal 
neurons compared with the lower frequencies (Weidner et al., 2002). Alternatively, 
the potentially decreased pain transmission might be due to the nerve refractory 
periods leading to the decreased efficiency of the neurotransmitter release following 
the 200 Hz stimulation (Randić et al., 1993). In study II, the pain ratings declined 
during the 10 Hz process which may be due to habituation or fatigue of nociceptors 
when the stimulus is repeatedly applied and lasting long time (Rankin et al., 2009; 
van den Broeke et al., 2012). The pain ratings in session two were lower than 
session one which was most probably considered to be due to learning effect, i.e., 
subjects get less pain in session two as a consequence of the previous pain 
experience in session one (Hopkins, 2000). The pain experience of 10 Hz CES 
process was lower than 100 Hz CES process which supports the finding that 
increase of pain at increasing frequencies as mechanosensitive nociceptors and A-δ 
fibres are prone to follow high-frequency electrical stimulation (Dusch et al., 2007). 
During neurogenic or inflammatory pain conditions, persistent low-frequency C-
fiber nociceptive input to the central nervous system may lead to hyperalgesia (Puig 
& Sorkin, 1996; Han et al., 2000; Xiao & Bennett, 2007b; Drdla & Sandkühler, 
2008). In fact, C-fiber nociceptor discharging tends to follow low frequency (1~10 
Hz) electrical stimulation but not the high frequencies electrical stimulation used to 
induce LTP-like pain amplification in experiments (Raymond et al., 1990). In 
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addition, different patterns of electrical stimulation are considered to act differently 
on nociceptive nerve endings resulting in different release of neuropeptides and 
inflammatory mediators which are important for inducing central sensitization, such 
as substance P (SP), bradykinin, calcitonin gene-related peptide (CGRP), glutamate, 
brain-derived neurotrophic factor (BDNF), etc. (Khan et al., 1992; Sauerstein et al., 
2000; Lever et al., 2001). A relative higher frequency electrical stimulation 
(frequency >2 Hz) is likely to play an important role in the release of peptidergic 
neurotransmitters (Bartfai et al., 1986) whereas the stimulation patterns are 
important for the neurotrophins releasing (Lever et al., 2001). Therefore, the 
different pain sensation between sessions may be related to different neuro-
mediators involved in different CES paradigms.  
In study III, the decreased pain ratings to CES in CPCS session reflected the effect 
of CPM. This indicated that the endogenous CPM inhibition depressed the pain 
transmission of CES. CPM activated by a conditioning noxious stimulus applied to 
a remote location of the body can inhibit the activity of convergent WDR neurons 
receiving both A- and C-fibre input; hence, the C-fibre response to noxious 
transcutaneous electrical stimulation could be depressed (Le Bars et al., 1979b). 
However, CPM showed a lack of inhibition effect on nociceptive specific neurons 
(Le Bars et al., 1979a). The peptidergic C-fibre nociceptive pathway might be 
selectively activated by the EPE according to the neurogenic vasodilation flare 
induced by axon reflex. The facilitation at superficial dorsal horn nociceptive 
specific and deep dorsal horn WDR neuron connections are important cellular 
mechanisms underlying central sensitization (Svendsen et al., 1999; Bester et al., 
2000; Ikeda et al., 2003). Therefore, the CPM inhibition on WDR neurons most 
probably is the underlying mechanism for the decreased pain ratings during the 
CES process in the CPCS session. Furthermore, the decreased pain ratings during 
the CES process indicated that the endogenous inhibition system might decrease the 
sensitization or the population of sensitized spinal cord neurons. In addition, the SF-
MPQ scores during the CES process were not different between two sessions 
indicating that the overall pain experience could not be affected by the CPCS. 
Hence, it can be speculated that CPM plays a major role depressing the pain 
intensity without showing any effect affecting the pain quality. 
2.4.  INFLAMMATION  RESPONSES  
 Main results  
In study I, no significant difference was found for the SBF between 100 Hz session 
and control session in the post-conditioning period. SBF was significantly increased 
within 10 min after 200 Hz CES sessions compared to the control session, after this, 
it declined. In study I, II, and III, SBF kept at a high level within 10~20 min after 
10 Hz CES, then gradually declined. The increased SBF lasted to the end of the 
observation period (i.e., 60 min) in every CES paradigm.  
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In study I, ST was not found to be different between all three CES paradigm 
sessions and the control session. No temporal changes were found for ST in all 
sessions. In study II, ST was found to decline throughout the observation period. 
However, no difference was found between the ST 10 min preCES, 10 min 
postCES, and 20 min postCES. No difference was observed between sessions. 
However, in study III, ST increased after CES in both sessions which lasted to the 
end of the observation period. 
In study II, no difference was found for SBF and ST between sessions. According 
to the ICC values within session (ICCwi) and between sessions (ICCbt)  
(ICCwi=0.79, ICCbt=0.62) and sample sizes estimation for crossover (Ncr) and 
parallel (Np) study designs (Ncr=3, Np=13), SBF showed acceptable reliability for 
measuring the neurogenic inflammation when employing 10 Hz CES healthy 
human model. If the drug effect were hypothesized to have a 30 % recovery of SBF 
after 10 Hz CES, three subjects would be needed for crossover studies and thirteen 
subjects would be needed for parallel studies. The Bland-Altman plot of SBF 
showed that the level of equality (i.e., the mean difference is zero) was within the 
confidence interval of the mean difference indicating no significant systematic 
difference was observed between two sessions which further confirmed the results 
of RM-ANOVA. The differences between two sessions were within the limits of 
agreement.   
In study III, no difference was found between CPCS and control sessions for both 
SBF and ST. 
 Discussion  
The CES-induced neurogenic inflammation was highly related to neuropeptides 
released from the peripheral nociceptors (Holzer, 1998).  In study I and II, SBF 
significantly increased after 10 Hz and 200 Hz CES paradigms most probably 
indicating the activation of peptidergic C-fibre nociceptors leading to axon reflex 
effects (Low & Westerman, 1989; Klein et al., 2004). However, the stimulation 
frequencies may act differently on peptidergic afferents leading to different levels 
of neurogenic vasodilatation. In study I, higher frequency CES (100 and 200 Hz) 
did not induce a higher blood flow compared with lower frequency (10 Hz) CES. 
This is supposed to be due to that nociceptors responsible for neurogenic 
vasodilation could not transfer all impulses delivered at high-frequency electrical 
stimulation, but had a conduction failure (Dusch et al., 2007). Moreover, compared 
to high-frequency stimulation, low-frequency stimulation showed a better effect to 
activate mechanical insensitive “silent” nociceptors which are important for the 
axon reflex flare and mechanical secondary hyperalgesia (Serra et al., 2004; Dusch 
et al., 2007; Hendry & Hsiao, 2012). In addition, it has been shown that SP mainly 
induces protein extravasation whereas CGRP is responsible for neurogenic 
vasodilatation (Holzer, 1998). In humans, SP and CGRP were found to be released 
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after electrical stimulation which caused a large flare reaction (Sauerstein et al., 
2000). In study II, the increased SBF which lasted for one hour after CES was 
reliable in both crossover and parallel study designs. This makes SBF assessment a 
reliable indicator for peripheral neurogenic inflammation to be measured in 
potential drug testing studies using 10 Hz CES human model. However, skin 
temperature was not an ideal indicator for recording inflammation responses 
induced by CES as no differences were found after CES compared to the control 
session in study I. Furthermore, ST appears to be easily affected by the surrounding 
circumstances as shown in the different changes in study I and study II. ST could be 
a reflection of the temperature in both superficial and deep tissues, whereas SBF 
was focusing on the blood flow changes in superficial skin layers. This also makes 
SBF a better choice as the circular pin electrodes work on the nociceptive nerve 
endings which also locate in superficial skin layers. A significant increase of SBF 
was found before CES in study I, II and III which were due to the process of 
determining DTh by a series of increasing and decreasing electrical pulses with low 
stimulation intensities. This process may activate the peptidergic Aδ-fibers (about 
20% of Aδ-fibers) and a small proportion of C-fiber nociceptors by the stimulation 
intensity below pain threshold (Beitel & Dubner, 1976; Georgopoulos, 1976; 
McCarthy & Lawson, 1989; Mouraux et al., 2010). 
In study III, the inflammation responses, including SBF and ST, were not different 
between CPCS session and control session, which indicated that both sessions could 
involve the same level of peripheral peptidergic nociceptors activation. This 
indicated that the inflammation responses were not affected by CPCS. Therefore, it 
is speculated that CPM effect could not affect the vasodilatation mediators released 
from peripheral nociceptive nerve endings. This further confirms that the CPM 
inhibitory effect on pain LTP may take effect at the central nervous system rather 
than at the peripheral organs. Furthermore, the same neurogenic inflammation 
findings (i.e., SBF) most likely indicated the similar amount of nociceptive input 
might be transmitted into the central nervous system in both sessions. The 
cardiovascular response (i.e. blood pressure) to the conditioning stimulus (i.e. cold 
water bath) was reported positively associated with the magnitude of CPM effect in 
healthy controls (Chalaye et al., 2013). However, the SBF was not influenced by 
CPM in the present study indicating only the systemic circulations but not 
superficial microvascular circulation is affected by CPCS. 
2.5. HOMOTOPIC PAIN RESPONSES  
 Main results 
In study I, the pain intensities to SES were found to increase and reach the plateau 
at 30 min in the post-conditioning period of all four sessions. However, no 
difference was found between any two sessions. In study II, the pain intensities to 
SES, however, were not found to change after the 10 Hz CES and no difference was 
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found between two sessions. The measurement of perception intensity to SES was 
reliable after reliability analysis (ICCwi=0.94, ICCbt=0.85). However, a large 
number of subjects (Ncr=634, Np=11310) would be needed if a 30% of recovery of 
perception intensity to baseline in potential crossover and parallel drug testing 
studies. Most of the differences between two sessions were within the limits of 
agreement. Furthermore, in study III, the pain perception intensities were not found 
to increase after CES in both sessions either. No difference was found for 
perception intensities to SES between CPCS and control sessions.  
 Discussion  
The homotopic LTP-like pain amplification is a rather complex phenomenon. In 
contrast to Klein’s study (Klein et al., 2004) which showed an increasing 
homotopic pain after high-frequency CES, the homotopic pain amplification was 
absent in all CES paradigms in study I, II and the control session in study III. 
However, this is in agreement with some other studies without finding a similar 
homotopic pain hyperalgesia either (van den Broeke et al., 2012; Matre et al., 2013). 
These three studies showed that the homotopic pain amplification was absent when 
comparing with control session (study I) and baseline values (study II and III). In 
animal experiments and slice preparations studies, both 100 Hz bursts of CES and a 
continuous train of 10 Hz CES were found to induce LTP at the spinal delay of 
neuro-connections (Terman et al., 2001; Kim et al., 2015). The homotopic pain 
amplification was thought probably to be a perceptual correlate of nociceptive 
homosynaptic LTP in spinal dorsal horn (Klein et al., 2004). The TRPV1 receptors 
in spinal dorsal horn, especially located at superficial layers, have been shown to be 
involved in spinal LTP induction and development (Yang et al., 2014). It has been 
reported that the TRPV1-positive C-fiber nociceptors are the main contributors for 
the induction of homotopic pain LTP, and TRPV1-negative C-fibers could induce a 
homotopic self-facilitation in the high-frequency CES paradigm (Henrich et al., 
2015). In addition, the heat pain hyperalgesia was absent in three studies which are 
in agreement with the study by Lang and colleagues (Lang et al., 2007). Primary 
thermal hyperalgesia was reported to be mainly due to sensitization of peripheral 
nociceptors, and it is an important feature of primary hyperalgesia (Treede et al., 
1992). The absence of heat pain hyperalgesia indicated that a lack of peripheral 
sensitization would be present in CES-induced pain LTP models or heat pain 
threshold is not a sensitive indicator for measuring heat pain hyperalgesia compared 
with suprathreshold heat pain stimuli (Yucel et al., 2002; van den Broeke & 
Mouraux, 2014b). The thermode with a large contact area may concomitantly 
activate mechanical low threshold afferent fibers when thermo-nociceptive laser 
stimuli can selectively activate Aδ- and C-fiber nociceptors (Plaghki & Mouraux, 
2003). The lack of homotopic pain amplification could be due to several reasons: 1) 
counter effects of LTP and LTD (long-term depression) resulting from activation of 
C-fiber and A-δ fiber nociceptive pathways by CES (Pfau et al., 2011); 2) 
habituation or fatigue because of repeated electrical stimulation, e.g., the fatigue of 
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C-fiber nociceptors after stepped noxious stimuli with interstimulus intervals less 
than 150 s (Slugg et al., 2000; Rankin et al., 2009); 3) hypoesthesia which could be 
induced by continuous 20 Hz CES at C-fiber strength (De Col & Maihöfner, 2008); 
4) the time interval is 10 min which may miss the temporal changes as shown in 
Klein’s study using 2 min interval, or 5) the technical reason that the EPE need to 
be removed and placed back to the original position which may change the 
impedance between EPE and skin. This may influence the intensity of SES. 
Reposition of the EPE could also bring variations which could mask the homotopic 
pain LTP that might be present. In addition, the intensity of single electrical 
stimulation might not be strong enough, or the pin electrode might not be thin 
enough to efficiently activate nociceptors when using a single pulse electrical 
stimulation. In study II, a minor effect of 10 Hz CES was observed to induce 
homotopic pain amplification which would require a large number of subjects to 
detect a 30% return to the baseline in potential crossover and parallel drug testing 
studies. This indicates that further studies are needed to explore the complex 
underlying mechanisms for homotopic pain amplification in humans.   
In study III, the homotopic pain ratings were not found to be inhibited by CPM. 
CPM induced an inhibitory effect on the pain LTP induction process which 
however did not affect the efficiency to develop pain amplification at the homotopic 
skin sites. As CPM seems to take less inhibition effect on nociceptive superficial 
spinal dorsal horn neurons which play an important role in the induction of 
nociceptive LTP (Le Bars et al., 1979a; Ikeda et al., 2003), therefore, the 
homotopic pain LTP might not be completely inhibited by CPM. However, the lack 
of pain amplification in the control session makes it hard to speculate the effect of 
CPM on homotopic pain responses. A similar absence of pain LTP to homotopic 
single electrical stimulation was also presented in the study from van den Broeke 
EN and colleagues whereas observing increased event-related potentials (van den 
Broeke et al., 2012). Therefore, the CPM inhibition on homotopic pain 
amplification could be reflected on the event-related potentials rather than on pain 
perceptions. This  needs further research in the future.  
2.6. HETEROTOPIC PAIN RESPONSES 
 Main results 
In study I, the perception intensities to heterotopic pinprick stimuli (12.8 g, 30 g) 
increased after all three CES paradigms (10 Hz, 100 Hz and 200 Hz) compared to 
the control session. The increased perception intensities reached to the plateau 30 
min in the post-conditioning period. No difference was found between any two of 
the CES paradigms.  
In study II, the pain intensities to higher weight heterotopic pinprick stimuli (30 g 
and 50.1 g) were found to increase within 10 min after 10 Hz CES in both sessions 
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whereas the perception intensity to lower weight pinprick stimulus (12.8 g) was 
found to increase 30 min after 10 Hz CES. The perception intensities in session one 
were higher than session two for 12.8 g and 30 g pinprick stimulators, whereas no 
difference was found for the perception intensity to 50.1 g pinprick stimulator 
between sessions. From the reliability results, the higher weight pinprick stimulator 
showed higher reliability based on ICC values and a higher weight pinprick 
stimulator required fewer subjects to detect a 30% return to the baseline (i.e., drug 
effect) in potential crossover and parallel drug testing studies (see more details in 
paper II).  
In study III, the time effect was found for both 30g and 50g pinprick stimulators. 
The perception intensity to 50.1 g pinprick stimulator increased after CES which 
lasted to the end of the observation period in both sessions. However, in 30 g 
pinprick stimulator testing, the perception intensities were not found to increase 
after CES in multiple comparisons with Bonferroni-Holm adjustments. The 
perception intensity to 12.8 g pinprick stimulator was not found increase after CES. 
The pain rating increments after CES were depressed only in 12.8 g pinprick testing 
at 40 and 50 min in the post-conditioning period (conditioning stimulus effect) of 
the CPCS session compared with the control session. The heterotopic stroking 
perception intensity increased after CES which lasted to the end of the observation 
period in both sessions. The heterotopic perception intensity increments to light 
stroking stimuli were found to be lower in the CPCS session compared with the 
control session.  
 Discussion  
In study I and II, all three (10, 100, 200 Hz) CES paradigms induced heterotopic 
perception intensity amplificatory states to pinprick (activate A-δ-fibre endings) and 
light stroking stimuli (activate A-β-fibre endings), however, without showing any 
significant difference between each paradigm. This indicated that all paradigms 
presented a similar effect to induce the facilitated surrounding unconditioned A-δ- 
and A-β-fibre pathways (Lang et al., 2007). It has been reported that pinprick pain 
is mainly mediated by TRPV1-negative A-fibres whereas LTP of TRPV1-positive 
C-fibres (major contribution) and A-fibres (minor contribution) neurotransmission 
is the main cause for heterotopic pinprick hyperalgesia (Ziegler et al., 1999; 
Henrich et al., 2015). Therefore, a potential interaction is speculated to happen 
between the two perception transmission pathways. The cutaneous pain 
amplification at the unconditioned skin site (secondary hyperalgesia) is considered 
to depend on central sensitization of spinal nociceptive neurons (Simone et al., 
1991). This is also in accordance with the study I and II that heterotopic perception 
amplification was most probably due to the central mechanisms rather than the 
peripheral mechanisms. First, the sites for pinprick stimuli are outside of 
neurogenic vasodilation flare which largely eliminates the potential influence of 
peripheral processes (Sumikura et al., 2003). Secondly, the increasing pinprick and 
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light stroking perception intensities did not follow the decreased peripheral SBF in 
the post-conditioning period indicating most probably heterotopic pain LTP comes 
from the central changes. One cause for heterotopic hyperalgesia could be due to 
mechanical insensitive “silent” nociceptors which could be activated by the CES 
(Serra et al., 2004; Hendry & Hsiao, 2012). Moreover, the convergence of A-fiber 
and C-fiber mediated nociceptive input in spinal dorsal horn WDR neurons provide 
the anatomic basis for heterotopic pain amplification. After CES applied on 
peripheral nociceptors, the release of diffusible neurogenic mediators, such as SP 
and CGRP, at the central terminals of peptidergic nociceptive fibers may expand to 
facilitate the nearby spinal neurons receiving mechanical A-fibers input (Liu et al., 
1994; Sumikura et al., 2003). The simultaneous LTP at heterosynaptic GABAergic 
synapses which was mediated by activating metabotropic glutamate receptors 
located at spinal lamina I neurons through glutamate released from primary 
afferents (Fenselau et al., 2011). In study II, the heterotopic pinprick perception 
amplification measurement showed better reliability for heavier weight pinprick 
stimulators and the heavier weight pinprick method need fewer subjects to detect a 
30% recovery to baseline in the 10 Hz paradigm. Moreover, this pinprick 
perception amplification lasted at least one hour which allowed a time course for 
potential drug testing. Strictly speaking, the pinprick perception amplification for 
12.8 g and 30 g stimulator can not be labelled hyperalgesia as the stimulus should 
be painful before CES and becomes more painful after CES (Loeser & Treede, 
2008). The light stroking perception amplification can not be labelled as allodynia 
either as the stimulus should not be painful before CES and should become painful 
after CES, but it is not the case either (Loeser & Treede, 2008). The possible 
reasons may be due to 1) the VAS scale in study II has a non-painful rating range 
that is different from study I and other studies which may miss the assessment to 
non-painful stimuli and the subjects probably also give a small number even it is 
not painful; or 2) the pinprick stimulators are different from the stimulators used in 
other studies in nature. Additionally, the learning effect could have a less influence 
on perception intensities to heavier weight pinprick stimulators between sessions. 
This will help to choose a more reliable and validated painful pinprick stimulator 
when assessing the mechanical punctate hyperalgesia in future studies. 
The heterotopic perception amplification after CES to non-painful mechanical 
stimuli including pinprick and light stroking stimuli was found to be depressed in 
the CPCS session compared with the control session in study III. In addition, in all 
three pinprick stimulators testing, a lower perception intensities always seemed to 
be present in CPCS session compared to the control session. This tendency of 
pinprick sensory changes indicated that the endogenous inhibition (i.e., CPM) 
might have inhibited the sensitization or population of sensitized spinal cord 
neurons which hence decreased the development of heterotopic pain amplification. 
Moreover, the decreased pain amplification to non-painful pinprick stimulus took 
place 40 min after CES whereas the reduction of light-stroking evoked perception 
intensities occurred 10 min after CES. This indicated that a slow desensitization 
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process might be involved after the induction of CPM. CPM inhibition could, at 
least partly, decrease the facilitation of mechanical stimuli transmission. Moreover, 
the different time courses of non-painful pinprick and light-stroking stimuli suggest 
their modulation by CPM is mediated by distinct mechanisms. In human studies, 
conditioning cold pressor test reduced the capsaicin-induced pain intensity and 
brush-evoked pain intensity (i.e., allodynia) but not the area of allodynia (Witting et 
al., 1998). This indicates CPM effect working on the magnitude and area of 
allodynia is selective but not general. LTP of WDR convergent neurons receiving 
nociceptive (C-fibers) and non-nociceptive stimuli (A-β fibers) which locate in deep 
dorsal horn play an important role in developing secondary hyperalgesia (Willis, 
1993; Svendsen et al., 1997, 1999). It has been shown that LTP can be induced 
after continuous 10 Hz CES at spinothalamic convergent neurons (Le Bars et al., 
1979a; Giesler et al., 1981; Kim et al., 2015). In addition, DNIC was able to 
modulate the activity of spinothalamic convergent neurons (Dickenson & Le Bars, 
1983). Therefore the CPM inhibitory effect on nociceptive WDR neurons could be 
a potential mechanism for the decreased heterotopic mechanical perception 
amplification. It can be speculated that CPM could decrease the sensitization level 
of the WDR neurons or  prevent a part of WDR neurons from being sensitized.  
CPM showed no inhibition effect on pain amplification to strong, painful pinprick 
stimulus. Moreover, CPM effect on CES process could not completely prevent the 
development of perception intensity amplification as it was still found in the CPSC 
session. It can be speculated that other potential mechanisms contributing to 
heterotopic pain amplification may not be affected by CPM: 1) The expansion of 
diffusible neuropeptides such as substance P or CGRP released from the central 
terminals of peptidergic fibers may cause facilitation of nearby A-δ and A-β 
neuropathways (Liu et al., 1994); 2) Glutamatergic excitatory interneurons could be 
activated by CES which may lead to the increased responsiveness of spinal 
nociceptive projection neurons (Santos et al., 2007); 3) Serotonergic descending 
facilitation deriving from the rostral ventromedial medulla of the brain stem may 
cause release of serotonins which could act on central terminals of Aδ-fibers or on 
NK1-receptor positive neurons in lamina I of the spinal dorsal horn (Pertovaara, 
1998; Suzuki et al., 2002; Zeitz et al., 2002). Therefore, to a certain extent, CPM 
inhibition system could be able to prevent heterotopic perception amplification to 
non-painful mechanical stimuli in cutaneous CES human model. The endogenous 
inhibitory pain modulation could help, at least in part, to relieve central  
sensitization in humans. 
2.7. PAIN-LTP IN CHRONIC PAIN PATIENTS 
 Discussion  
The time course of LTP-like pain amplification phenomena demonstrated in the 
human CES model corresponds to the early phase of LTP demonstrated in animal 
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models which primarily involves the post-translational modifications like 
phosphorylation of NMDA- and AMPA-receptors (Klein et al., 2006). The post-
translational effects lead to an enhancement of postsynaptic currents boosting 
synaptic efficacy which play an important role in the maintenance of sensitization 
of spinal cord neurons (Lynch, 2004). The long-lasting and enlarged area of 
secondary hyperalgesia is often involved in the development of chronic pain after 
surgery in clinical studies (De Kock et al., 2001, 2005; Lavand’homme et al., 2005; 
Wilder-Smith et al., 2010). Moreover, hyperalgesia to mechanical and electrical 
stimuli is a typical feature of various chronic pain states, including fibromyalgia 
(Lautenbacher et al., 1994), rheumatoid arthritis (Leffler et al., 2002), osteoarthritis 
(Kosek & Ordeberg, 2000), low back pain (O’Neill et al., 2007), irritable bowel 
syndrome (Verne & Price, 2002), headache (de Tommaso et al., 2008), gallstones 
(Giamberardino et al., 2005), and pancreatitis (Dimcevski et al., 2007). 
Inflammatory and neuropathic conditions resulting in amplified nociceptive input 
and spontaneous afferent discharging could lead to enhanced nociceptive barrage 
into the spinal dorsal horn (Jensen & Baron, 2003). This process may be similar to 
the CES-induced pain LTP process.  Spinal nociceptive LTP has been proposed to 
be a potential cellular mechanism that can be considered to partially explain the 
long lasting pain amplification in chronic pain states. Therefore, an effective way to 
prevent LTP induction or reverse the established pain LTP states is promising in 
preventing or treating chronic pain states. In human volunteer models, a variety of 
pharmacological interventions have been found to be able to inhibit the stimulus-
induced secondary hyperalgesia and allodynia. First, reduce synaptic transmission 
at the first nociceptive synapses, such as the classical opioid receptor agonists 
(Eisenach et al., 1997; Wallace, Ridgeway, et al., 2002; Wang et al., 2008). Second, 
directly interfere with the NMDA receptor activation, such as ketamine, a non-
specific NMDA receptor agonist (Warncke et al., 2000; Wallace, Barger, et al., 
2002; Wallace, Ridgeway, et al., 2002). Third, interfere with additional sources of 
activity-dependent intracellular Ca
2+
 rise, such as gabapentinoids, a voltage-gated 
calcium channel modulator (Chizh et al., 2007). Therefore, there are many 
pharmacological interventions can be tested for inhibiting the heterotopic pain 
amplification by 10 Hz CES paradigm which could be more resemble the sustained 
low frequency discharging of C-fiber nociceptors during inflammatory/neuropathic 
pain conditions. This provides a better understanding of CES-induced pain LTP in 
human models which will help to explore pain alleviating interventions in clinical 
studies.  
2.8. CPM IN CHRONIC PAIN PATIENTS  
 Discussion  
CPM has been shown to be in dysfunction (i.e. less efficient) in most chronic pain 
patients compared with healthy controls (Lewis et al., 2012), such as osteoarthritis 
and muscle pain (Kosek & Ordeberg, 2000), whiplash associated disorders (Daenen 
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et al., 2013; Ng et al., 2013), irritable bowel syndrome (Chang, 2005), fibromyalgia 
(Kosek & Hansson, 1997; Lautenbacher & Rollman, 1997), temporomandibular 
disorder (Maixner et al., 1995) and migraine and tension-type headache (Sandrini et 
al., 2006). The decreased CPM effect was supposed to be due to two possible 
reasons: 1) the long-term exhausting of endogenous pain inhibition function during 
the persistent chronic pain or 2) a less inhibitory CPM might be present already at 
the beginning to predispose pain (Yarnitsky, 2015). However, it is still difficult to 
clarify this question until now. It has been reported that only brain structure lesions 
but without ongoing pain can not lead a decreased efficiency of CPM; this indicates 
that the presence of clinical pain may be a necessary contributor to dysfunctional 
endogenous inhibition in chronic pain patients (Willer et al., 1990; Perrotta et al., 
2012). However, CPM antinociceptive pathway could be modified after pain-
relieving surgery (Kosek & Ordeberg, 2000). It has been suggested that the 
efficiency of CPM before surgery could be used as a biomarker to predict chronic 
post-surgical pain; a less efficient CPM pre-surgery could be at risk developing 
chronic pain (Yarnitsky et al., 2008; Landau et al., 2010; Wilder-Smith et al., 2010). 
In addition, the efficiency of CPM could predict the drug effect for alleviating pain; 
as a less efficient CPM could have a stronger drug effect for pain relief (Yarnitsky 
et al., 2012). In animal study, efficient endogenous descending inhibition could 
protect against the development of chronic neuropathic pain (De Felice et al., 2011). 
In study III, the decreased pain ratings during CES process after CPCS would 
indicate that CPM effect should be efficient in the process to induce pain 
facilitation. The decreased heterotopic perception amplification to non-painful 
mechanical stimuli indicated that pain LTP as a state of pronociception and efficient 
CPM as a state of antinociception have a counteracting effect between each other. 
In clinical studies, cold pressor test also depressed dynamic mechanical allodynia in 
neuropathic pain patients whereas a lack of inhibition when using ischemic 
conditioning painful stimulus has been observed (Witting et al., 2003; Tuveson et 
al., 2007). This also indicates that the endogenous pain modulating system, to a 
certain extent, can alter chronic neuropathic allodynia. The clinical implication 
from study III is that the endogenous pain inhibition may counteract the pain 
facilitated process in the central nervous system at the early phase of pain 
chronification which may intend to inhibit the development of allodynia in patients.
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3. CONCLUSIONS AND 
PERSPECTIVES 
The CES-induced perception intensity amplification in healthy humans has been 
used as a surrogate model for hyperalgesia and allodynia in persistent inflammatory 
or neuropathic pain patients (Klein et al., 2004; van den Broeke et al., 2012; Matre 
et al., 2013). The EPE used in this model can selectively activate superficial nerve 
endings which are from unmyelinated C- and myelinated A-fibre nociceptor in the 
skin (Klein et al., 2004, 2008; Hansen et al., 2007; van den Broeke & Mouraux, 
2014a). Therefore, this model can be used to mimic the discharging frequency of 
nociceptors irritated by nociceptive stimuli in certain inflammatory and neuropathic 
pain conditions. The peripheral CES may change the properties of central 
nociceptive neurons in the spinal dorsal horn which facilitates ascending 
nociceptive pathway. A better understanding of this model can help to explore the 
mechanisms underlying pain chronification and pain modulation. Moreover, from a 
clinical point of view, these results are important for future pharmacological testing 
studies when applying this healthy human model. A further exploration of the 
counteraction between endogenous pain inhibition and pain facilitation will help to 
better understand the mechanisms behind pain modulation.  
From study I, we found that both relative continuous low frequency (10 Hz) and 
bursts of high frequency (200 Hz) CES were able to induce heterotopic pain-LTP 
like the traditional bursts of 100 Hz CES whereas with an absence of homotopic 
pain-LTP in all CES paradigms.  However, it is still difficult for CES paradigm to 
completely mimic the irregular discharging pattern of nociceptors. Therefore, 10 Hz 
CES which is specially closer to the rather low frequency discharging of 
nociceptors during inflammatory and neuropathic pain conditions can be a better 
alternative paradigm inducing pain-LTP in humans. High-frequency CES probably 
caused more conduction failure of electrical stimulation impulses into the central 
nervous system. From study II, we found that 10 Hz CES paradigm was still able to 
induce heterotopic pain-LTP but without showing the homotopic pain-LTP. The 10 
Hz CES-induced neurogenic inflammation and heterotopic pain-LTP to painful 
pinprick and non-painful light stroking stimuli showed acceptable reliability. From 
study I and II, the pain perception amplification at the homotopic site may involve a 
far more complex pain transmission and modulation process, or the methodology 
differences between other studies may result in the absence of homotopic pain-LTP. 
As a counterpart of pain facilitation system, the pain inhibitory system may 
counteract with the facilitated pathways which may decrease the efficiency of pain 
amplification. As WDR neurons located at deep dorsal horn playing an important 
role in nociceptive LTP can be depressed by CPM demonstrated by a “pain inhibits 
pain” phenomenon. Therefore, both nociceptive LTP and CPM have the same 
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working point in the spinal cord. Based on this theory, in study III, we found a 
decreased pain perception intensity during the CES process and decreased 
heterotopic perception intensity amplification to non-painful mechanical stimuli 
indicating that the endogenous pain inhibition system may play a role in preventing 
pain facilitation.  
 Conclusions: 
 
1. Both low-frequency (10 Hz) and high-frequency (200 Hz) CES paradigms can 
induce heterotopic mechanical perception amplification like the traditional 100 
Hz CES paradigm but 10 Hz CES is associated with a less pain during the 
CES process (Study I).  
2. Based on sample size calculation and reliability analysis for the outcome 
measures, in 10 Hz CES-induced pain LTP human model, superficial blood 
flow is reliable for neurogenic inflammation assessment and painful pinprick 
and light stroking stimuli are reliable for measuring heterotopic perception 
amplification (Study II).  
3. CPM can depress heterotopic mechanical LTP-like perception amplification to 
non-painful mechanical pinprick and light stroking stimuli whereas not to 
painful pinprick stimuli. CPM may not modulate homotopic pain perception 
and peripheral neurogenic inflammation (Study III). 
 
 Limitations and Perspectives: 
 
1. The reposition of EPE during the measurement of the homotopic pain 
amplification in this project may cause variations and mask pain perception 
changes. Therefore, further research with fixed EPE placed on the skin would 
provide more comprehensive understanding for homotopic pain LTP. 
2. The stimulation intensity of SES used in this project (10Dth) might not be 
strong enough when using single electrical pulse to activate neurogenic 
nociceptors. Therefore, SES with stronger stimulation intensities (20DTh or 
higher) may activate nociceptors more efficiently which may help to present 
homotopic pain LTP.  
3. The pin electrodes used in this project might be not thin enough to efficiently 
activate superficial nociceptive nerve endings. Therefore, from a technical 
point of view, a thinner pin electrodes may be a  potential further research to 
compare the efficiency to induce LTP-like cutaneous pain amplification in the 
future.  
4. In study I and II, there was no non-CES control session/site. The absence of 
homotopic pain LTP compared to the baseline assessments might be due to 
habituation to SES. Therefore, it is possible that habituation may have covered 
the homotopic pain LTP. The participation of non-CES control session/site 
would increase the scientific impact of the study.  
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5. Event-related potentials (ERPs) can be used to investigate the responsiveness 
of the central nervous system to electrical stimuli when there are no changes of 
pain perception in the homotopic area.  
6. Compared with high-frequency CES, 10 Hz CES is closer to discharging 
frequency of nociceptors during inflammatory/neuropathic pain conditions. 
Therefore, 10 Hz CES paradigm may have more biological significance and 
can be used in potential drug testing studies. 
7. The electrical stimulation patterns can be further explored in future studies to 
be more like the irregular low frequency discharging, such as the number of 
impulses or bursts, burst time intervals, bursts of different frequencies, 
stimulation time duration, electrical stimulation intensity, etc.  
8. CPM, as shown to be dysfunctional in chronic pain patients, showed its pain 
modulatory role in the development of cutaneous pain amplification after CES. 
This not only provides a better understanding of CPM endogenous pain 
inhibitory function but may also help to develop new and efficient analgesic 
treatments which could specially interact with CPM in chronic pain patients.  
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